| Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes (NCT00729898) | Novo Nordisk A/S | 2008-03-01 |
| Effect of rIL-21 on Metastases in Lymph Nodes in Melanoma Skin Cancer (NCT00601861) | Novo Nordisk A/S | 2008-02-13 |
| Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689 (NCT00623194) | Novo Nordisk A/S | 2008-02-01 |
| Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin (NCT00676741) | Novo Nordisk A/S | 2008-02-01 |
| The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus (NCT00620282) | Novo Nordisk A/S | 2008-02-01 |
| An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment (NCT00698269) | Novo Nordisk A/S | 2008-02-01 |
| Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus (NCT00687284) | Novo Nordisk A/S | 2008-02-01 |
| Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus (NCT00655200) | Novo Nordisk A/S | 2008-02-01 |
| Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes (NCT00660374) | Novo Nordisk A/S | 2008-02-01 |
| Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00627445) | Novo Nordisk A/S | 2008-02-01 |
| Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily (NCT00634842) | Novo Nordisk A/S | 2008-02-01 |
| Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes (NCT00700765) | Novo Nordisk A/S | 2008-01-01 |
| Comparison of Two NN5401 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes (NCT00614055) | Novo Nordisk A/S | 2008-01-01 |
| Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes (NCT00700830) | Novo Nordisk A/S | 2008-01-01 |
| Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide (NCT00745433) | Novo Nordisk A/S | 2008-01-01 |
| Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes (NCT00704574) | Novo Nordisk A/S | 2008-01-01 |
| Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus (NCT01868529) | Novo Nordisk A/S | 2008-01-01 |
| Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes (NCT00613951) | Novo Nordisk A/S | 2008-01-01 |
| Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin (NCT00670722) | Novo Nordisk A/S | 2008-01-01 |
| Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes (NCT00612040) | Novo Nordisk A/S | 2008-01-01 |
| Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database (NCT00853086) | Novo Nordisk A/S | 2008-01-01 |
| Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00614120) | Novo Nordisk A/S | 2008-01-01 |
| Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes (NCT00611884) | Novo Nordisk A/S | 2008-01-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects (NCT01868555) | Novo Nordisk A/S | 2007-12-01 |
| A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy Volunteers (NCT01603342) | Novo Nordisk A/S | 2007-12-01 |
| Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes (NCT00671008) | Novo Nordisk A/S | 2007-12-01 |
| Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers (NCT00665665) | Novo Nordisk A/S | 2007-11-01 |
| Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea (NCT00455858) | Novo Nordisk A/S | 2007-11-01 |
| Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin (NCT00669864) | Novo Nordisk A/S | 2007-11-01 |
| Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard® (NCT00658099) | Novo Nordisk A/S | 2007-11-01 |
| Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer (NCT00523380) | Novo Nordisk A/S | 2007-10-04 |
| Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes (NCT00537303) | Novo Nordisk A/S | 2007-10-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs (NCT00537277) | Novo Nordisk A/S | 2007-10-01 |
| Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany (NCT00665808) | Novo Nordisk A/S | 2007-10-01 |
| Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins (NCT00657319) | Novo Nordisk A/S | 2007-10-01 |
| Investigation of 2 Different Oral Formulations of Estradiol and Norethisterone in Healthy Women (NCT01596010) | Novo Nordisk A/S | 2007-10-01 |
| Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes (NCT00698126) | Novo Nordisk A/S | 2007-10-01 |
| Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial (NCT00542620) | Novo Nordisk A/S | 2007-09-01 |
| Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes (NCT00712478) | Novo Nordisk A/S | 2007-09-01 |
| Observational Study to Evaluate the Safety of Levemir® in Diabetes (NCT00706017) | Novo Nordisk A/S | 2007-09-01 |
| Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma (NCT00523042) | Novo Nordisk A/S | 2007-08-30 |
| Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx® (NCT01034202) | Novo Nordisk A/S | 2007-08-01 |
| Pharmacokinetics of Insulin Detemir in Healthy Chinese Male Subjects (NCT01498939) | Novo Nordisk A/S | 2007-08-01 |
| Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00518882) | Novo Nordisk A/S | 2007-08-01 |
| Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes (NCT00824668) | Novo Nordisk A/S | 2007-08-01 |
| Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients (NCT00617253) | Novo Nordisk A/S | 2007-07-12 |
| Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes (NCT00506662) | Novo Nordisk A/S | 2007-07-01 |
| Observational Study of Patients With Diabetes Using Levemir® FlexPen® (NCT00670683) | Novo Nordisk A/S | 2007-07-01 |
| Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes (NCT00509925) | Novo Nordisk A/S | 2007-07-01 |
| Observational Study to Evaluate the Safety While Using Levemir® (NCT00701155) | Novo Nordisk A/S | 2007-07-01 |
| The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis (NCT00503698) | Novo Nordisk A/S | 2007-07-01 |
| Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects (NCT03144271) | Novo Nordisk A/S | 2007-06-11 |
| Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™ (NCT00675220) | Novo Nordisk A/S | 2007-06-01 |
| Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control (NCT00700960) | Novo Nordisk A/S | 2007-06-01 |
| Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds (NCT00486278) | Novo Nordisk A/S | 2007-06-01 |
| Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD) (NCT00472953) | Novo Nordisk A/S | 2007-05-15 |
| Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes (NCT00655044) | Novo Nordisk A/S | 2007-05-01 |
| Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes (NCT00715351) | Novo Nordisk A/S | 2007-05-01 |
| Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes (NCT00474045) | Novo Nordisk A/S | 2007-05-01 |
| Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes (NCT00665093) | Novo Nordisk A/S | 2007-05-01 |
| Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes (NCT00469092) | Novo Nordisk A/S | 2007-05-01 |
| Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes (NCT00469586) | Novo Nordisk A/S | 2007-04-26 |
| Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus. (NCT00476437) | Novo Nordisk A/S | 2007-04-01 |
| French National Registry of Children Born Small for Gestational Age Treated With Somatropin (NCT01578135) | Novo Nordisk A/S | 2007-03-18 |
| Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes (NCT00709917) | Novo Nordisk A/S | 2007-03-01 |
| Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes (NCT00447382) | Novo Nordisk A/S | 2007-03-01 |
| Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes (NCT00825253) | Novo Nordisk A/S | 2007-03-01 |
| Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes (NCT00715663) | Novo Nordisk A/S | 2007-02-01 |
| Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes (NCT00435019) | Novo Nordisk A/S | 2007-02-01 |
| Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers (NCT01513525) | Novo Nordisk A/S | 2007-02-01 |
| The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes (NCT00422058) | Novo Nordisk A/S | 2007-01-10 |
| Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes (NCT00427154) | Novo Nordisk A/S | 2007-01-10 |
| Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis (NCT00431132) | Novo Nordisk A/S | 2007-01-01 |
| Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment (NCT01561937) | Novo Nordisk A/S | 2007-01-01 |
| Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes (NCT01565733) | Novo Nordisk A/S | 2007-01-01 |
| An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment (NCT00696995) | Novo Nordisk A/S | 2007-01-01 |
| Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis (NCT01486979) | Novo Nordisk A/S | 2007-01-01 |
| Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™ (NCT01500486) | Novo Nordisk A/S | 2007-01-01 |
| Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers (NCT01515553) | Novo Nordisk A/S | 2007-01-01 |
| Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects (NCT01865331) | Novo Nordisk A/S | 2006-12-01 |
| The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD (NCT00521690) | Novo Nordisk A/S | 2006-12-01 |
| Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes (NCT00411892) | Novo Nordisk A/S | 2006-11-29 |
| Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women (NCT01508858) | Novo Nordisk A/S | 2006-11-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00393718) | Novo Nordisk A/S | 2006-11-01 |
| Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes (NCT00399711) | Novo Nordisk A/S | 2006-11-01 |
| Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice (NCT01492166) | Novo Nordisk A/S | 2006-11-01 |
| Metabolism and Excretion of Liraglutide in Healthy Male Volunteers (NCT01517568) | Novo Nordisk A/S | 2006-11-01 |
| Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes (NCT00348712) | Novo Nordisk A/S | 2006-10-30 |
| Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes (NCT00343980) | Novo Nordisk A/S | 2006-10-10 |
| Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos (NCT01542489) | Novo Nordisk A/S | 2006-10-01 |
| Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00395746) | Novo Nordisk A/S | 2006-10-01 |
| Evaluation of Safety and Parameters of Application Technique (NCT01516242) | Novo Nordisk A/S | 2006-10-01 |
| Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes (NCT01517555) | Novo Nordisk A/S | 2006-10-01 |
| Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes (NCT00659282) | Novo Nordisk A/S | 2006-09-11 |
| Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes (NCT01865318) | Novo Nordisk A/S | 2006-09-01 |
| Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes (NCT01865305) | Novo Nordisk A/S | 2006-09-01 |
| Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00383877) | Novo Nordisk A/S | 2006-09-01 |
| Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes (NCT00331604) | Novo Nordisk A/S | 2006-08-31 |
| The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction (NCT01542476) | Novo Nordisk A/S | 2006-08-01 |
| Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes (NCT01865292) | Novo Nordisk A/S | 2006-08-01 |